Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP472120.RA1CDaRKhKj75SSAhxtDWOaeqnLT8vSMXNSyJBN0oxOd0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP472120.RA1CDaRKhKj75SSAhxtDWOaeqnLT8vSMXNSyJBN0oxOd0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP472120.RA1CDaRKhKj75SSAhxtDWOaeqnLT8vSMXNSyJBN0oxOd0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP472120.RA1CDaRKhKj75SSAhxtDWOaeqnLT8vSMXNSyJBN0oxOd0130_provenance.
- NP472120.RA1CDaRKhKj75SSAhxtDWOaeqnLT8vSMXNSyJBN0oxOd0130_assertion description "[Of the entire group, p15 and p16 alteration and positive TGF-alpha (> or =cutoff value) were significantly expressed in schistosomal bladder cancer (68.1%, 60.9%, and 65.2%), and squamous cell carcinoma type (SCC) (69.1%, 64.7% and 72.1%) compared to those with non-schistosomal bladder cancer (29.4%, 7.8%, and 37.3%) or transitional cell carcinoma (TCC) (28.8%, 3.8%, and 28.8), respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP472120.RA1CDaRKhKj75SSAhxtDWOaeqnLT8vSMXNSyJBN0oxOd0130_provenance.
- NP472120.RA1CDaRKhKj75SSAhxtDWOaeqnLT8vSMXNSyJBN0oxOd0130_assertion evidence source_evidence_literature NP472120.RA1CDaRKhKj75SSAhxtDWOaeqnLT8vSMXNSyJBN0oxOd0130_provenance.
- NP472120.RA1CDaRKhKj75SSAhxtDWOaeqnLT8vSMXNSyJBN0oxOd0130_assertion SIO_000772 15589816 NP472120.RA1CDaRKhKj75SSAhxtDWOaeqnLT8vSMXNSyJBN0oxOd0130_provenance.
- NP472120.RA1CDaRKhKj75SSAhxtDWOaeqnLT8vSMXNSyJBN0oxOd0130_assertion wasDerivedFrom befree-2016 NP472120.RA1CDaRKhKj75SSAhxtDWOaeqnLT8vSMXNSyJBN0oxOd0130_provenance.
- NP472120.RA1CDaRKhKj75SSAhxtDWOaeqnLT8vSMXNSyJBN0oxOd0130_assertion wasGeneratedBy ECO_0000203 NP472120.RA1CDaRKhKj75SSAhxtDWOaeqnLT8vSMXNSyJBN0oxOd0130_provenance.
- befree-2016 importedOn "2016-02-19" NP472120.RA1CDaRKhKj75SSAhxtDWOaeqnLT8vSMXNSyJBN0oxOd0130_provenance.